The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...

The African Union (AU) and the European Union (EU) will hold a high-level meeting on Wednesday, 5 November 2025, to renew ...

Victorian researchers have developed a world-first RNA drug to prevent the damaging effects of lupus, marking a breakthrough ...

Grit Biotherapeutics Co., Ltd. ("Grit Bio"), a leading clinical-stage biopharmaceutical company pioneering next-generation ...

CastleVax, a clinical-stage biotechnology company developing intranasal vaccines using its attenuated Newcastle Disease Virus (NDV)-based vaccine platform, announced today that the first participant ...

Vancouver, Canada, November 4th, 2025, FinanceWire Equity Insider News Commentary – The precision medicine sector reached ...

A biotech stock with strong FDA approval odds this November may see limited upside amid a full valuation and a pending lawsuit.

GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing multi-antigen vaccines and immunotherapies for infectious diseases and cancer, today announced that it will report ...

The production of cell and gene therapies faces stringent regulatory requirements that demand the use of high-quality, animal-free raw materials to ensure patient safety and product consistency. Many ...

It’s notoriously tough to land a political blow on Donald Trump, but California congressman Ro Khanna is one of the few ...

Key market opportunities in the shingles vaccine sector include rising elderly populations; expanding healthcare ...

Patients with implanted medical devices like orthopedic joint replacements, pacemakers, and artificial heart valves run a ...